CPMG Inc
- SEC CIK
- 0001372218
- Latest filing
- May 15, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 4
- −1 vs. Q2 2022
- Portfolio value
- $509.9M
- +$12.1M (+2.4%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRCTPROCEPT BioRobotics Corp | COM | 9,055,341 | $375.4M | 73.6% | −1,863,052−17.1% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 2,896,901 | $72.8M | 14.3% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 8,218,467 | $39.8M | 7.8% | 00.0% | Unchanged | History |
| APENApollo Endosurgery, Inc. | COM | 3,963,641 | $21.8M | 4.3% | +58,416+1.5% | Added | History |
Sold out since Q2 2022 (1)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| iShares Tr464287622 | RUS 1000 ETF | 2,871 | $596.0K | 0.1% | – |